BPC-157 and Tirzepatide Interaction

Compatible
Researched 90% confidence

BPC-157 and Tirzepatide have a compatible interaction with 90% confidence. No known interactions, may support gut health and reduce GI effects. These compounds primarily affect different organ systems.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Half-life: <30 minutes Typical dose: 250-500mcg healing, longevity
vegf anticoagulantcarcinogenic riskpro angiogenicteratogenic
View full profile

Tirzepatide

Dual GIP/GLP-1 Receptor Agonist | Weight Loss & Diabetes

Dual agonist targeting both GIP and GLP-1 receptors, producing glucose-dependent insulin stimulation, delayed gastric emptying, glucagon suppression, and central satiety signaling via hypothalamic pathways..

Half-life: ~5 days (120 hours) Typical dose: 2.5mg starting, titrate up to 5-15mg weekly weight loss, metabolic
glp1 receptor teratogenic
View full profile

Combined Organ Load

Blood Vessels
low
GI Tract
low
Pancreas
low

Shared Safety Flags

2x 2 compounds share the teratogenic safety flag (BPC-157, Tirzepatide). Monitor accordingly.

Frequently Asked Questions

Can I take BPC-157 with Tirzepatide?

Yes, BPC-157 and Tirzepatide can generally be taken together. No known interactions, may support gut health and reduce GI effects.

Is BPC-157 and Tirzepatide safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between BPC-157 and Tirzepatide?

No known interactions, may support gut health and reduce GI effects. This assessment has 90% confidence and is based on documented research data.

How should I time BPC-157 and Tirzepatide?

BPC-157 has a half-life of <30 minutes and Tirzepatide has a half-life of ~5 days (120 hours). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: BPC-157 vs Tirzepatide

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.